Blue Water Vaccines, Inc. is a biotechnology company that focuses on the research and development of transformational vaccines to prevent infectious diseases worldwide. Its vaccine platform has molecular properties that enable delivery of various antigens, which can be utilized to develop singular or multi-targeted vaccines. The company's influenza vaccine program uses proprietary technology to identify specific epitopes, or proteins, with cross-reactive properties that enable the potential development of a universal flu vaccine. Its pipeline includes novel vaccine candidates licensed from research institutions and seeks to develop vaccines that provide long-lasting immunity to harmful viral and bacterial pathogens that cause infections in patient populations with high unmet needs. The company was founded by Joseph Hernandez on October 26, 2018 and is headquartered in Cincinnati, OH.
NASDAQ
